There actually is a concept in CEPA called “the best place to act”, which recognizes that sometimes CEPA is not the best place to take the regulatory action. It might be better under the Food and Drugs Act, the cosmetic regulations, the Canada Consumer Product Safety Act or somewhere else.
CEPA might be the piece of legislation that will assess the substance to determine what risk management might need to happen, but that risk management could well happen elsewhere. I think that is what you're speaking about: that it's not always CEPA that needs to be the piece of legislation that's regulating.